Wednesday, December 31, 2008

Manufacturer warns of serious infections related to psoriasis drug

From CBC News:
The manufacturer of a drug that treats psoriasis has issued new safety information for doctors and patients.

EMD Serono Canada says Raptiva has been associated with a risk of serious infections, including progressive multifocal leukoencephalopathy, a rare and sometimes fatal brain disorder.

Raptiva suppresses the body's immune response to reduce psoriasis inflammation; however, the company says that by diminishing the body's natural defence system, it can also increase the risk of serious infections in some patients.

Signs and symptoms of PML may include difficulty thinking, walking or speaking, or other behavioural changes, weakness, loss of balance or co-ordination, visual impairment, partial paralysis of one side of the body, or seizures.

Other serious infections may be indicated by fever, weakness, cough, flu-like symptoms, warm, red or painful skin, or open sores on the body. ...more

No comments: